By Memorandum Opinion entered by The Honorable Maryellen Noreika in ANI Pharmaceuticals, Inc. v. Method Pharmaceuticals, LLC et al., Civil Action No. 17-1097-MN (D.Del. January 11, 2019), the Court granted-in-part Defendants’ Motion to Dismiss under Federal Rule of Civil Procedure 12(b)(2) or, in the Alternative, Transfer Venue to the extent that it sought to

By Memorandum Opinion entered by The Honorable Gregory M. Sleet in Constant Contact Inc. v. Umbanet Inc., Civil Action No. 12-1467 (D.Del., March 12, 2014), the Court granted defendant Umbanet’s Motion to Transfer the declaratory judgment action filed by plaintiff Constant Contact to the United States District Court for the District of New Jersey.

By Memorandum Opinion entered by Chief Judge Gregory M. Sleet in Devicor Medical Products, Inc. v. Biopsy Sciences, LLC, Civil Action No. 10-1060-GMS (D.Del., April 15, 2013), the Court denied the amended motion to transfer venue of Defendant Biopsy Sciences, LLC. After analyzing whether the action could have been brought originally in the Middle

By Report and Recommendation entered in Fuisz Pharma LLC v. Theranos, Inc., Civil Action No. 11-1061-SLR-CJB (D.Del., May 18, 2012), the Honorable Christopher J. Burke recommends that the Court grant the motion of defendant Theranos to dismiss, stay or transfer in part by transferring the case to the United States District Court for the Northern

By Memorandum Opinion entered by the Honorable Richard G. Andrews in the consolidated cases of Robocast, Inc. v. Apple, Inc., Civil Action No. 11-235-RGA (D.Del., February 24, 2012) and Robocast, Inc. v. Microsoft Corporation, Civil Action No. 10-1055-RGA (D.Del., February 24, 2012), the Court denied the motions to transfer of defendants Apple and